Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, K.-W.
Right arrow Articles by Prather, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, K.-W.
Right arrow Articles by Prather, R. S.
Agricola
Right arrow Articles by Park, K.-W.
Right arrow Articles by Prather, R. S.
Biology of Reproduction 65, 1681-1685 (2001)
© 2001 Society for the Study of Reproduction, Inc.


Regular Article

Developmental Potential of Porcine Nuclear Transfer Embryos Derived from Transgenic Fetal Fibroblasts Infected with the Gene for the Green Fluorescent Protein: Comparison of Different Fusion/Activation Conditions1

Kwang-Wook Parka, Liangxue Laia, Hee-Tae Cheonga, Gi-Sun Ima, Qing-Yuan Suna, Guangming Wua, Bill N. Daya, and Randall S. Prather2,a

a Department of Animal Sciences, University of Missouri-Columbia, Columbia, Missouri 65211


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The in vitro developmental potential of porcine nuclear transfer (NT) embryos was evaluated. Oocytes were matured for 42–44 h, and metaphase II-oocytes were enucleated. Fetal fibroblasts infected with the enhanced green fluorescent protein (EGFP) gene were serum-starved for 3–5 days. A single cell was injected into the perivitelline space of the enucleated oocytes. The reconstructed oocytes were allocated to different fusion and activation conditions. In experiment 1, two different fusion/activation conditions were compared: two pulses of 1.2 kV/cm for 30 µsec (group A), or one pulse of 1.6 kV/cm for 30 µsec followed in 30 min by one pulse of 1.2 kV/cm for 30 µsec (group B). Parthenogenetic controls were created by using the group A parameter. The fusion rate in group A (mean ± SEM, 68.4% ± 3.9%) was higher (P < 0.05) than in group B (59.4% ± 2.3%). The rates of cleavage (50.1% ± 4.6% to 62.8% ± 5.5%) were not different among control and treatment groups. However, the rate of parthenogenetic control embryos developing to the blastocyst stage (18.1% ± 3.1%) was higher (P < 0.05) than the rate of NT embryos (5.9% ± 1.7% and 4.9% ± 2.5%). In experiment 2, we compared two pulses of 1.2 kV/cm (group C) versus two pulses of 1.3 kV/cm (group D). For two control groups, the same pulses as those given to group C or D, respectively, were supplied. The fusion rate in group D (70.6% ± 4.2%) was higher (P < 0.05) than in group C (58.9% ± 2.7%). The cleavage rates were not different among control and treatment groups (58.1% ± 8.1% to 73.6% ± 6.0%). However, the rate of embryos developing to the blastocyst stage in group D (3.5% ± 1.7%) was lower (P < 0.05) than in controls and group C (11.4% ± 2.0% to 16.4% ± 1.1%). In experiment 3, we examined whether the presence of cytochalasin B (CB) during donor cell injection affects the development of NT embryos. The fusion rate of oocytes in the group with CB (78.4% ± 1.4%) was higher (P < 0.05) than in the group without CB (70.9% ± 0.2%). The cleavage rate of the control group (85.5% ± 4.9%) was higher (P < 0.05) than those of the treatment groups (61.6% ± 2.7% and 63.9% ± 4.3%). However, the rates of embryos developing to the blastocyst stage (8.1% ± 2.5% to 19.1% ± 6.0%) and the mean cell number of blastocysts (29.4 ± 5.2 to 45.7 ± 6.4) were not different among control and treatment groups. Green fluorescence was observed at all stages in NT embryos. These results indicate that two pulses of 1.2 kV/cm are enough for fusion/activation of NT embryos to develop to the blastocyst stage, and that the presence of CB during donor cell injection is not necessary for early development of NT embryos.

developmental biology, early development, embryo, gene regulation, ovum


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The development of nuclear transfer (NT) embryos derived from porcine somatic cells has been reported by several groups [16]. Recently, four groups have succeeded in producing live offspring from somatic cells [710]. Several kinds of fusion and/or activation methods have been used. Most groups [1, 4, 5, 7, 9] have applied additional pulses or chemical stimuli for activation after fusion. Cytochalasin B (CB), which depolymerizes microfilaments, is used during micromanipulation of oocytes in vitro. Most groups [1, 35, 7, 9] have used CB during enucleation and donor cell injection in porcine NT. However, we observed that when donor cells were placed in CB-containing medium, the cell membranes blebed more easily than when placed in non-CB-containing medium. This damage to cells might affect the development of NT embryos. In the present study, we examined the effects of several fusion/activation (FA) conditions or of CB addition during donor cell injection on the development of NT embryos to simplify the NT procedure. In addition, the expression of enhanced green fluorescent protein (EGFP) in embryos was monitored during culture.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Media

The medium used for maturation of oocytes was tissue culture medium (TCM) 199 (no. 31100-035; Gibco, Grand Island, NY) supplemented with 0.1% (w/v) polyvinyl alcohol, 3.05 mM D-glucose, 0.91 mM sodium pyruvate, 0.57 mM cysteine, 0.5 µg/ml of LH (L-5269; Sigma Chemical Co, St. Louis, MO), 0.5 µg/ml of FSH (F-2293; Sigma), 10 ng/ml of epidermal growth factor (E-4127; Sigma), 75 µg/ml of penicillin G, and 50 µg/ml of streptomycin.

The medium used for enucleation was TCM 199 supplemented with 0.3% BSA and 7.5 µg/ml of CB, and the medium for injection was the same medium (with or without CB). The medium used for activation consisted of 0.3 M mannitol, 1.0 mM CaCl2·H2O, 0.1 mM MgCl2·6H2O, and 0.5 mM HEPES.

The medium used for the culture of reconstructed embryos was North Carolina State University-23 medium [11] supplemented with 0.4% BSA.

Collection and Culture of Cumulus-Oocyte Complexes

Ovaries were collected from prepubertal gilts at a local abattoir and transported to the laboratory in 0.9% NaCl solution at 35–39°C. Cumulus-oocyte complexes (COCs) were aspirated from 2- to 6-mm diameter antral follicles with an 18-gauge needle fixed to a 10-ml disposable syringe. The COCs were washed three times in maturation medium, and 50–60 COCs were transferred to 500 µl of the same medium that had been covered with mineral oil in a four-well multidish (Nunc, Roskilde, Denmark) and equilibrated at 39°C in an atmosphere of 5% CO2 in air overnight.

Preparation of Fetal Fibroblasts

A porcine fetus was obtained from pregnant gilt at Day 35 after insemination, and the tissue was cut into small pieces with fine scissors. The cells were incubated for 30 min at 37°C in PBS containing 0.05% trypsin and 0.5 mM EDTA, and this suspension was centrifuged [6]. The cell pellet was resuspended and cultured in Dulbecco modified Eagle medium supplemented with 75 µg/ml of penicillin G, 50 µg/ml of streptomycin, and 15% (v:v) fetal calf serum. The cells were passaged up to seven times.

EGFP Gene Infection into Fetal Fibroblasts

To generate transgenic cells, a replication-defective vector based on Moloney murine leukemia virus, pseudotyped with the envelope glycoprotein of vesicular stomatitis virus (VSV-G), was used. Retroviral vector pseudotyped with VSV-G was carrying an EGFP gene under the control of the CMV promoter (LNCE-[VSV-G]), which was kindly provided by Dr. A.W.S. Chan [12]. The LNCE had long terminal repeat (L), neomycin-resistant gene (N), cytomeyalovirus (CMV) promoter (C), and EGFP gene (E). A 0.75-kilobase fragment containing the entire coding region of EGFP gene was recovered by HpaI and HindIII digestion of the EGFP expression vector, pEGFP-N1 (Clontech Laboratories, Inc., Palo Alto, CA). The EGFP gene fragment was inserted into the HpaI and HindIII sites of the multiple cloning site in the retrovirus expression vector, pLNCX (Clontech). The EGFP gene was regulated by a CMV promoter; the final vector was named pLNC-EGFP [12]. The pLNC-EGFP was stably transduced into a 293 GP packaging cell line. The EGFP-expressing cell line was sorted by flow cytometry and selected by using neomycin (G-418). The packaging cell was infected with VSV-G. The supernatant was collected and concentrated by ultracentrifugation [12]. The viral titer was determined, and the aliquoted solution was stored at -80°C.

The cells were infected with the retroviral vector by the following procedures: Polybrene (0.1%) was diluted 1:30 (v/v) with 0.1x HBS medium (22.9 mM Hepes, 140.3 mM NaCl, and 0.7 mM NaH2PO4·H2O). Three hundred microliters of the diluted medium were added to 4 µl of vector solution (108 cfu/ml). The solution was diluted in 5 ml of culture medium and incubated overnight. The G-418 selection was started the following day and continued for 13 days, and then the cells were frozen. Cells were a pool of infected cells and not from a single colony. Cells were thawed, cultured, and then serum-starved (0.5% serum) for 3–5 days before NT (Fig. 1).



View larger version (165K):
[in this window]
[in a new window]
 
FIG. 1. EGFP expression in fetal fibroblasts (FFs) infected with the EGFP gene and effect of CB on morphological change in FFs. A) FFs under normal light. A') EGFP expression in FFs under fluorescein isothiocyanate filter set. B) FFs in non-CB-containing medium after 10 min of culture. B') FFs in CB-containing medium after 10 min of culture showing many blebed cell membranes

Micromanipulation

After 42–44 h of culture, oocytes were freed from cumulus cells by vigorous vortexing for 4 min in TL-Hepes [11] supplemented with 0.1% polyvinyl alcohol and 0.1% hyaluronidase. Cumulus-free (denuded) oocytes were enucleated by aspirating the first polar body and adjacent cytoplasm in enucleation medium with a glass pipette (diameter, 30 µm). A single donor cell was placed in the perivitelline space of the oocyte to contact the oocyte membrane.

Fusion/Activation of Oocytes

Injected oocytes were placed between 0.2-mm-diameter platinum electrodes 1 mm apart in activation medium. Fusion/activation was induced with DC pulses on a BTX Elector-Cell Manipulator 200 (BTX, San Diego, CA) according to the experimental design.

Culture of Embryos

After FA, 20–30 reconstructed embryos were transferred to a 50-µl drop of culture medium covered with mineral oil in a 35-mm dish, and the dishes were held in 5% CO2 in air at 39°C. Nonmanipulated oocytes were electrically activated and cultured as controls. Some reconstructed embryos were stained with 5 µg/ml of bisbenzimide (Hoechst 33342) to identify nuclei by using an epifluorescent microscope (Nikon, Melville, NY). After 6 days of culture, all embryos were stained with Hoechst 33342 to determine the number of nuclei by using an epifluorescent microscope, and embryos with two or more nuclei were determined to have cleaved. For detection of EGFP expression, embryos were examined on an epifluorescent microscope using a standard fluorescein isothiocyanate filter set.

Experimental Design

In experiment 1, we compared two different FA conditions: two successive DC pulses of 1.2 kV/cm for 30 µsec (group A), or one DC pulse of 1.6 kV/cm for 30 µsec followed in 30 min by one DC pulse of 1.2 kV/cm for 30 µsec (group B). Parthenogenetic controls were created by using the group A parameter. The reconstructed embryos were cultured for 6 days, examined, and stained to count the number of nuclei.

In experiment 2, we compared two successive DC pulses of 1.2 kV/cm for 30 µsec (group C) versus two successive DC pulses of 1.3 kV/cm for 30 µsec (group D). For two parthenogenetic controls, the same pulses as those given to group C or D were supplied, respectively. The reconstructed embryos were cultured for 6 days.

In experiment 3, we examined whether the presence of CB during donor cell injection affects the development of NT embryos. Cells were placed in the perivitelline space of enucleated oocytes in injection medium with CB (+CB) or without CB (-CB). The NT and parthenogenetic controls were created by using the group A parameter of experiment 1. The reconstructed embryos were cultured for 6 days.

Statistical Analysis

Data were analyzed by analysis of variance and Duncan multiple-range test by using the general linear models in the Statistical Analysis System software to determine treatment differences. All percentage data were subjected to arcsine transformation before statistical analysis. Data are expressed as the mean ± SEM. A probability of P < 0.05 was considered to be statistically significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
After culture, 81.6% (1199/1470) of the oocytes had a polar body. Because Hoechst 33342, a DNA-specific dye, is detrimental to pig embryo development [13], we did not employ this compound to confirm enucleation of oocytes. However, staining of enucleated oocytes not used for NT showed that 89.8% of those evaluated (247/275) were enucleated after manipulation.

In experiment 1, the fusion rate in group A (68.4% ± 3.9%) was higher (P < 0.05) than in group B (59.4% ± 2.3%). The rates of cleavage (50.1% ± 4.6% to 62.8% ± 5.5%) were not different among control and treatment groups. However, the rate of embryos developing to the blastocyst stage in the control (18.1% ± 3.1%) was higher (P < 0.05) than in treatments (5.9% ± 1.7% and 4.9% ± 2.5%) (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Effect of two different FA methods on development of NT embryos

In experiment 2, the fusion rate in group D (70.6% ± 4.2%) was higher (P < 0.05) than in group C (58.9% ± 2.7%). The cleavage rates were not different among control and treatment groups (58.1% ± 8.1% to 73.6% ± 6.0%). However, the rate of embryos developing to the blastocyst stage in group D (3.5% ± 1.7%) was lower (P < 0.05) than in controls and group C (11.4% ± 2.0% to 16.4% ± 1.1%) (Table 2).


View this table:
[in this window]
[in a new window]
 
TABLE 2. Effect of two different FA methods on the development of NT embryos

In experiment 3, the fusion rate of oocytes of the +CB group (78.4% ± 1.4%) was higher (P < 0.05) than in the -CB group (70.9% ± 0.2%). The cleavage rate in the control group (85.5% ± 4.9%) was higher (P < 0.05) than in the treatment groups (61.6% ± 2.7% and 63.9% ± 4.3% in +CB and -CB, respectively). However, the rates of embryos developing to the blastocyst stage (8.1% ± 2.5% to 19.1% ± 6.0%) and the mean cell number of blastocysts (29.4 ± 5.2 to 45.7 ± 6.4) were not different among control and treatment groups, respectively (Table 3).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Effect of CB during cell injection on development of NT embryos

Figure 2 shows the EGFP expression in several stages of NT embryos. Before fusion, EFGP was observed only in the donor cell. However, EGFP was observed from 1 h postfusion to the blastocyst stage in all embryos. Most fused embryos had pronuclei at 18 h (fusion time was considered to be 0 h) (Fig. 2C'). Cleavage (Fig. 2D) was observed at 26 h, and embryos had developed to the 4-cell stage by 50 h (Fig. 2E) and to the 8-cell stage by 74 h (Fig. 2F). Compaction and blastocoele formation (Fig. 2G) occurred between the 8- and 16-cell stage (98 h), and a hatching blastocyst (Figs. 2H and 3A) was observed at 146 h.



View larger version (60K):
[in this window]
[in a new window]
 
FIG. 2. NT embryo development from fusion to blastocyst stage. All embryos expressed EGFP at all stages. Fusion time was considered to be 0 h. AH) Embryos under normal light. A'H') Embryos stained with Hoechst 33342 under ultraviolet light to identify the nuclei number. A''H'') Embryos under fluorescein isothiocyanate filters to identify EGFP. AA'') Reconstructed oocyte before fusion. Nucleus and EGFP expression was detected only in the donor cell. BB'') Fused embryo at 1 h. Embryos expressed EGFP. CC'') One-cell stage at 18 h. Pronucleus was easily identified. DD'') Two-cell stage at 26 h. EE'') Four-cell stage at 50 h. FF'') Eight-cell stage at 74 h. GG'') Sixteen-cell stage at 98 h. Embryo was compacted, and blastocoele began to form. HH'') Blastocyst stage at 146 h. This embryo had 100 nuclei


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present study demonstrates that synchronized FA can provide porcine NT embryos with the ability to develop to the blastocyst stage, and that CB is not necessary during donor cell injection. Moreover, all developmental stages of porcine NT embryos from fusion to the blastocyst stage are, to our knowledge, recorded here for the first time.

The blastocyst formation rate was 8%, and the mean cell number of blastocysts was 34–46 (range, 11–100) (Table 3). Blastocyst formation and the cell number of blastocysts were examined at Day 6 of culture. Betthauser et al. [9], who reported the first piglets produced from an in vitro maturation system, showed 7% blastocyst formation and a mean cell number of 66 (range, 16–125) when cultured for 7 days. Because those authors cultured embryos one more day compared to our system, the results cannot be compared directly. However, assuming a cleavage division per day, our results are quite comparable. Koo et al. [4] reported 10% blastocysts and a mean cell number of 30 (range, 23–65) when cultured for 6 days. Both groups applied activation stimuli after fusion. However, the developmental potential [4, 9] to the blastocyst stage is similar to our simultaneous FA system. This indicates that their activation stimuli [4, 9] might not be necessary, or that the other stimuli might be necessary for normal activation if fusion stimuli are not sufficient to activate NT embryos. Both groups used a single pulse of 1.6 kV/cm [4] or 1.9 kV/cm [9] for fusion. These fusion pulses are higher than ours (1.2 kV/cm), but we supplied two pulses. However, direct comparison is difficult because of several differences in the fusion and culture system.

Cytochalasin B is commonly used during micromanipulation of oocytes in vitro in several species, including Sus scrofa (pig). However, when donor cells were placed in CB-containing medium, the cell membranes blebed out and were broken more easily when aspirated into the pipette than when placed in non-CB-containing medium (Fig. 1, C and D). Therefore, the population of smooth surface cells from which to select is reduced in CB-containing medium. Nuclei of smooth-surface cells are more capable of early morphological reprogramming of nuclei (nuclear envelope breakdown, chromosome condensation, and pronuclear formation) than nuclei of rough-surface cells [1]. It is easier to find smooth cells in non-CB-containing medium than in CB-containing medium. Moreover, the in vitro developmental potential is not different in either medium (Table 3). Therefore, CB is not necessary during donor cell injection.

To our knowledge, this is the first report in which the developmental process of transgenic NT embryos is recorded from fusion to the blastocyst stage. Uhm et al. [3] showed some 2- and 4-cell stage and blastocyst stage embryos, but other stages were not described. Koo et al. [5] showed just the blastocyst stage. In the present study, the time of fusion was considered to be 0 h, and we recorded embryo development every day (Fig. 2). Fusion occurred within 1 h, and embryos cleaved by Day 2. Four-, 8-, and 16-cell stage embryos were observed at Days 2, 3, and 4, respectively. Compaction occurred between the 8- to 16-cell stage. Blastocoele formation began from the 16-cell stage. Blastocysts were observed from Day 5, and some hatching occurred at Day 6. From Day 7, blastocysts became degenerated and collapsed. The mean cell number of blastocysts was 34–46 (Table 3). Wang et al. [14] reported fewer cells within in vitro-produced, Day 6 blastocysts (37.3) compared to in vivo-derived, Day 6 embryos (164.5).

Uhm et al. [3] and Koo et al. [5] reported in vitro development of porcine NT embryos using EGFP-infected fetal fibroblasts. However, they reported EGFP expression in embryos without a negative control. In this study, we showed the lack of fluorescence in parthenogenetic controls to confirm EGFP expression of NT blastocysts (Fig. 3). Koo et al. [5] showed mean cell number, but Uhm [3] did not describe the quality of embryos. In the present study, we found that EGFP was detected from at least 1 h postfusion to the blastocyst stage. Theoretically, EGFP expression in just-fused embryos resulted from protein in the cytoplasm of the donor cells. Some protein and mRNA [15] from the donor cells are introduced into the cytoplasm of oocytes during cell fusion. After fusion, the EGFP protein and mRNA would be dispersed into the cytoplasm of oocytes and be detected, and EGFP mRNA could produce EGFP in the cytoplasm. Moreover, the timing of the transition from maternal to zygotic control of embryonic development (maternal to zygotic transcript transition) is the 4-cell stage in the pig [16]. Therefore, if the donor nucleus is remodeled and reprogrammed, detectable EGFP during the early embryo stage (before the 4-cell stage) should result from the donor cell cytoplasm, but detection of EGFP at later stages (especially the blastocyst stage) should result from new transcription from the NT nucleus.



View larger version (81K):
[in this window]
[in a new window]
 
FIG. 3. EGFP is expressed only in NT embryos and not in parthenogenetic embryos (arrow). A) A blastocyst stained with Hoechst 33342 under ultraviolet light to identify the nuclei number. A') A blastocyst under fluorescein isothiocyanate filters to identify EGFP

In conclusion, we simplified the FA protocol in porcine NT. This system is viable for porcine NT, because cloned piglets have been produced by using this system [10].


    FOOTNOTES
 
First decision: 29 May 2001.

1 Supported by Food for the 21st Century and the NCRR13438. Back

2 Correspondence: Randall Prather, University of Missouri, 162 ASRC, 920 East Campus Drive, Columbia, MO 65211. FAX: 573 884 7827;pratherr{at}missouri.edu Back

Accepted: July 16, 2001.

Received: May 3, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Tao T, Boquest AC, Machaty Z, Peterson AL, Day BN, Prather RS. Development of pig embryos by nuclear transfer of cultured fetal fibroblast cells. Cloning 1999; 1:55-62
  2. Tao T, Macháty Z, Boquest AC, Day BN, Prather RS. Development of pig embryos reconstructed by microinjection of cultured fetal fibroblast cells into in vitro matured oocytes. Anim Reprod Sci 1999; 56:133-141[CrossRef][Medline]
  3. Uhm SJ, Kim NH, Kim T, Chung HM, Chung KH, Lee HT, Chung KS. Expression of enhanced green fluorescent protein (EGFP) and neomycin resistant (Neo® genes in porcine embryos following nuclear transfer with porcine fetal fibroblasts transfected by retro virus vector. Mol Reprod Dev 2000; 57:331-337[CrossRef][Medline]
  4. Koo D-B, Kang Y-K, Choi Y-H, Park JS, Han S-K, Park IY, Kim S-U, Lee K-K, Son D-S, Chang W-K, Han Y-M. In vitro development of reconstructed porcine oocytes after somatic cell nuclear transfer. Biol Reprod 2000; 63:986-992[Abstract/Free Full Text]
  5. Koo D-B, Kang Y-K, Choi Y-H, Park JS, Kim H-N, Kim T, Lee K-K, Han Y-M. Developmental potential and transgene expression of porcine nuclear transfer embryos using somatic cells. Mol Reprod Dev 2001; 58:15-21[CrossRef][Medline]
  6. Kühholzer B, Tao T, Machaty Z, Hawley RJ, Greenstein JL, Day BN, Prather RS. Production of transgenic porcine blastocysts by nuclear transfer. Mol Reprod Dev 2000; 56:145-148[CrossRef][Medline]
  7. Polejaeva IA, Chen S-H, Vaught TD, Page RL, Mullins J, Ball S, Dai Y, Boone J, Walker S, Ayares DL, Colman A, Campbell KHS. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 2000; 407:86-90[CrossRef][Medline]
  8. Onishi A, Iwamoto M, Akita T, Mikawa S, Takeda K, Awata T, Hanada H, Perry ACF. Pig cloning by microinjection of fetal fibroblast nuclei. Science 2000; 289:1188-1190[Abstract/Free Full Text]
  9. Betthauser J, Forsberg E, Augenstein M, Childs L, Eilertsen K, Enos J, Forsythe T, Golueke P, Jurgella G, Koppang R, Lesmeister T, Mallon K, Mell G, Misica P, Pace M, Pfister-Genskow M, Strelchenko N, Voelker G, Watt S, Thompson S, Bishop M. Production of cloned pigs from in vitro system. Nature Biotechnol 2000; 18:1055-1059[CrossRef][Medline]
  10. Park K-W, Cheong H-T, Lai L, Im G-S, Kühholzer B, Bonk A, Samuel M, Rieke A, Day BN, Murphy CN, Carter DB, Prather RS. Production of cloned swine that express the enhanced green fluorescent protein. Anim Biotechnol 2001; (in press)
  11. Petters RM, Wells KD. Culture of pig embryos. J Reprod Fertil Suppl 1993; 48:61-73[Medline]
  12. Chan AWS, Chong KY, Martinovich C, Simerly C, Schatten G. Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science 2000; 291:309-312[Abstract/Free Full Text]
  13. Tao T, Machaty Z, Abeydeera LA, Day BN, Prather RS. Optimization of porcine oocyte activation following nuclear transfer. Zygote 2000; 8:69-77[CrossRef][Medline]
  14. Wang WH, Abeydeera LR, Han Y-M, Prather RS, Day BN. Morphologic evaluation and actin filament distribution in porcine embryos produced in vitro and in vivo. Biol Reprod 1999; 60:1020-1028[Abstract/Free Full Text]
  15. Parry TW, Prather RS. Carry-over of mRNA during nuclear transfer in pigs. Reprod Nutr Dev 1995; 35:313-318
  16. Jarrell VL, Day BN, Prather RS. The transition from maternal to zygotic control of development occurs during the 4-cell stage in the domestic pig. Sus scrofa: quantitative and qualitative aspects of protein synthesis. Biol Reprod 1991; 44:62-68[Abstract]



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
N. Van Thuan, S. Wakayama, S. Kishigami, H. Ohta, T. Hikichi, E. Mizutani, H.-T. Bui, and T. Wakayama
Injection of Somatic Cell Cytoplasm into Oocytes Before Intracytoplasmic Sperm Injection Impairs Full-Term Development and Increases Placental Weight in Mice
Biol Reprod, May 1, 2006; 74(5): 865 - 873.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Hyun, G. Lee, D. Kim, H. Kim, S. Lee, D. Nam, Y. Jeong, S. Kim, S. Yeom, S. Kang, et al.
Production of Nuclear Transfer-Derived Piglets Using Porcine Fetal Fibroblasts Transfected with the Enhanced Green Fluorescent Protein
Biol Reprod, September 1, 2003; 69(3): 1060 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
V. Bordignon, R. Keyston, A. Lazaris, A. S. Bilodeau, J. H.F. Pontes, D. Arnold, G. Fecteau, C. Keefer, and L. C. Smith
Transgene Expression of Green Fluorescent Protein and Germ Line Transmission in Cloned Calves Derived from In Vitro-Transfected Somatic Cells
Biol Reprod, June 1, 2003; 68(6): 2013 - 2023.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y.H. Choi, C.C. Love, Y.G. Chung, D.D. Varner, M.E. Westhusin, R.C. Burghardt, and K. Hinrichs
Production of Nuclear Transfer Horse Embryos by Piezo-Driven Injection of Somatic Cell Nuclei and Activation with Stallion Sperm Cytosolic Extract
Biol Reprod, August 1, 2002; 67(2): 561 - 567.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K.-W. Park, L. Lai, H.-T. Cheong, R. Cabot, Q.-Y. Sun, G. Wu, E. B. Rucker, D. Durtschi, A. Bonk, M. Samuel, et al.
Mosaic Gene Expression in Nuclear Transfer-Derived Embryos and the Production of Cloned Transgenic Pigs from Ear-Derived Fibroblasts
Biol Reprod, April 1, 2002; 66(4): 1001 - 1005.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, K.-W.
Right arrow Articles by Prather, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, K.-W.
Right arrow Articles by Prather, R. S.
Agricola
Right arrow Articles by Park, K.-W.
Right arrow Articles by Prather, R. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS